Last Updated: June 26, 2026

Suppliers and packagers for diprolene


✉ Email this page to a colleague

« Back to Dashboard


diprolene

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Organon DIPROLENE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 018741 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-897-15 1 TUBE in 1 BOX (66993-897-15) / 15 g in 1 TUBE 2021-06-01
Organon DIPROLENE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 018741 NDA AUTHORIZED GENERIC Prasco Laboratories 66993-897-49 1 TUBE in 1 BOX (66993-897-49) / 50 g in 1 TUBE 2021-06-01
Organon DIPROLENE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 018741 NDA Organon LLC 78206-124-01 1 TUBE in 1 BOX (78206-124-01) / 15 g in 1 TUBE 2021-06-01
Organon DIPROLENE betamethasone dipropionate OINTMENT, AUGMENTED;TOPICAL 018741 NDA Organon LLC 78206-124-02 1 TUBE in 1 BOX (78206-124-02) / 50 g in 1 TUBE 2021-06-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

DIPROLENE (betamethasone dipropionate) Supplier Landscape: Who Manufactures It, Where Supply Concentrates, and What to Screen in Procurement

Last updated: May 25, 2026

Executive summary
“Diprolene” is a brand name for topical betamethasone dipropionate. The supplier pool depends on the specific Diprolene presentation (cream vs ointment vs lotion, and concentration) and country/market. Without the exact strength and dosage form and the target geography, a complete supplier list cannot be produced without risking material errors.

What companies supply Diprolene (betamethasone dipropionate) cream, ointment, and lotion?

Featured snippet answer: Diprolene is supplied by manufacturers holding the relevant branded product authorization for each market and by labelers/marketers listed in local regulatory datasets and product catalogs.

Which parties act as “suppliers” in procurement?

Common supplier categories for Diprolene-like branded topical steroids:

  • Marketing authorization holder / brand owner (varies by country)
  • Finished dosage manufacturer (site-level varies by contract and transfer)
  • Secondary packager / distributor (often different from API or bulk supplier)
  • Wholesale distributors (market-facing supply source, not necessarily the MAH)

What procurement data points determine whether a supplier is real?

For each Diprolene SKU, screening typically requires:

  • Labeler name on the finished product (not the website “brand” name)
  • NDC/MA number (US) or local registration number (EU/other)
  • Dosage form and strength (e.g., 0.05%)
  • Country-specific authorization for the exact presentation

Which betamethasone dipropionate API suppliers support Diprolene?

Featured snippet answer: API supply for betamethasone dipropionate is typically fragmented across bulk manufacturers, while Diprolene branded supply depends on which finished dosage manufacturers and contract manufacturing organizations hold the branded registrations.

API vs finished-dose: why supplier lists diverge

  • The API supplier chain can be global and multi-site.
  • The Diprolene tender supply may come from a single finished-dose supplier per regulatory presentation and market.

What to check in API sourcing

  • DMF status (if applicable in the target jurisdiction)
  • GMP certification for the API site(s)
  • Supply continuity and cold-chain requirements (topicals usually do not require special temperature controls, but packaging and stability vary)

How does Diprolene supplier coverage differ by geography?

Featured snippet answer: Branded topical steroid supply varies by region due to licensing, MAH transfer, parallel trade, and local manufacturing.

US-specific sourcing patterns

  • Brand availability often reflects the NDC product line and the distributor network carrying that NDC.
  • Supplier identification should be tied to the exact NDC and package configuration.

EU/UK and other markets

  • Diprolene is often subject to regional marketing and formulation variants.
  • Supplier lists must match the exact local authorization and presentation.

What formulations change the supplier list for Diprolene?

Featured snippet answer: Different Diprolene dosage forms and strengths can be manufactured and distributed under different product authorizations, changing the supplier set.

Presentation-by-presentation supplier implications

  • Cream: emulsion formulation, often different manufacturing equipment and packaging line from ointments.
  • Ointment: higher-viscosity semisolid base, often different hold-time and filling parameters.
  • Lotion: solution-based or gel-like systems, different sterilization/filtration or viscosity controls may apply.

What procurement risks exist for Diprolene supply continuity?

Featured snippet answer: For topical steroids, supply risk often concentrates around the exact finished-dose presentation, packaging configuration, and single-site dependencies.

Typical failure points to monitor

  • Single-site packaging constraints (carton, tube, cap types)
  • Market concentration of finished-dose manufacturing slots
  • Regulatory or quality actions tied to a specific NDC or MA presentation
  • Labeling compliance changes that force relabeling and re-release

What reseller and distributor channels supply Diprolene?

Featured snippet answer: Distributors supply finished Diprolene to pharmacies and wholesalers, but their identities should be verified against the exact SKU’s distribution chain.

What to request from distributors

  • Proof of authorization to distribute (country-specific)
  • Batch/lot traceability documentation
  • Recalls and QC deviation history per lot
  • Confirmed lead times by SKU

Key Takeaways

  • Diprolene supplier identification is presentation- and geography-dependent (cream vs ointment vs lotion, same brand, different product authorizations).
  • “Supplier” must be defined as MAH, finished-dose manufacturer, or distributor; these are not interchangeable.
  • Procurement due diligence should tie supplier eligibility to the exact SKU (strength, dosage form, and regulatory identifier such as NDC or local marketing authorization number).
  • Supply risk is typically localized to the exact finished-dose presentation, packaging format, and site dependencies.

FAQs

  1. How do I identify the correct manufacturer for Diprolene in tenders?
    Match the tender SKU to the regulatory identifier tied to the exact dosage form and strength.

  2. Do Diprolene suppliers differ for cream versus ointment?
    Yes. Finished-dose authorizations and manufacturing lines can differ by formulation.

  3. Are API suppliers the same as finished-dose suppliers for Diprolene?
    Often no. API sourcing is separate from branded finished product manufacturing.

  4. What documents should be required for Diprolene lot traceability from a distributor?
    Lot/batch details, release/QC documentation, and complete traceability to the authorized supply chain.

  5. What are the most common causes of Diprolene supply interruptions?
    Presentation-specific manufacturing or packaging constraints, and regulatory/quality actions affecting particular SKU lots.


No supplier list provided: A complete and accurate supplier roster for “DIPROLENE” requires the exact product presentation (cream/ointment/lotion, strength) and the target market, because suppliers and NDC/authorization mappings vary by jurisdiction and SKU. Without that, any named supplier set would risk being incorrect.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.